EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates

Angeliki Kontou iD, Maria Kourti iD, Elias Iosifidis iD, Kosmas Sarafidis iD, Emmanuel Roilides iD

Antibiotics · 19.06.2023 · 12 (6) · 1072

DOI: 10.3390/antibiotics12061072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 19.06.2023. Verfasst von Angeliki Kontou und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Neonatology and Neonatal Intensive Care Unit, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki,…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance has become a significant public health problem globally with multidrug resistant Gram negative (MDR-GN) bacteria being the main representatives. The emergence of these pathogens in neonatal settings threatens the well-being of the vulnerable neonatal population given the dearth of safe and effective therapeutic options. Evidence from studies mainly in adults is now available for several novel antimicrobial compounds, such as new β-lactam/β-lactamase inhibitors (e.g., ceftazidime–avibactam, meropenem–vaborbactam, imipenem/cilastatin–relebactam), although old antibiotics such as colistin, tigecycline, and fosfomycin are also encompassed in the fight against MDR-GN infections that remain challenging. Data in the neonatal population are scarce, with few clinical trials enrolling neonates for the evaluation of the efficacy, safety, and dosing of new antibiotics, while the majority of old antibiotics are used off-label. In this article we review data about some novel and old antibiotics that are active against MDR-GN bacteria causing sepsis and are of interest to be used in the neonatal population.

Schlagwörter

Stichwörter der Autor:innen

ceftazidime–avibactamceftolozane/tazobactamcolistinfosfomycinimipenem/cilastatin–relabactammeropenem–vaborbactamneonatestigecycline

Autor:innen und Institutionen

  • 1st Department of Neonatology and Neonatal Intensive Care Unit, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki 54642, Greece.
  • Infectious Diseases Unit, 3rd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki 54642, Greece.
  • Basic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece.

ORCID-Profile: Angeliki Kontou, Maria Kourti, Elias Iosifidis, Kosmas Sarafidis, Emmanuel Roilides

Zitieren

APA

Kontou, A., Kourti, M., Iosifidis, E., Sarafidis, K., & Roilides, E. (2023). Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates. Antibiotics, 12(6), 1072. https://doi.org/10.3390/antibiotics12061072

Vancouver

Kontou A, Kourti M, Iosifidis E, Sarafidis K, Roilides E. Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates. Antibiotics. 2023;12(6):1072. doi:10.3390/antibiotics12061072

BibTeX
@article{Kontou2023,
  author = {Kontou, Angeliki and Kourti, Maria and Iosifidis, Elias and Sarafidis, Kosmas and Roilides, Emmanuel},
  title = {Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {1072},
  doi = {10.3390/antibiotics12061072}
}
Kostenlos starten →